Washington - The U.S. Food and Drug Administration (FDA) has granted marketing approval for Aldara (imiquimod) Cream 5 percent for the treatment of actinic keratoses (AK) on the face or scalp in immunocompetent adults.
FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
AAD 2023 Pearls from Zoe Diana Draelos, MD
New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients
2 Clarke Drive Cranbury, NJ 08512